KYVERNA is pioneering a new class of treatments and potential cures for serious autoimmune diseases. Our therapeutic platform combines advanced T cell engineering and synthetic biology technologies to suppress and eliminate the autoreactive immune cells at the root cause of inflammatory diseases.

Engineered

T Cell Therapies

for Autoimmune Diseases

KYVERNA is pioneering a new class of treatments and potential cures for serious autoimmune diseases. Our therapeutic platform combines advanced T cell engineering and synthetic biology technologies to suppress and eliminate the autoreactive immune cells at the root cause of inflammatory diseases.

JOIN OUR TEAM OF MISSION-DRIVEN SCIENTISTS AND PROFESSIONALS
developing groundbreaking and transformative therapies for patients with autoimmune diseases.

CAREERS

News

| Kyverna Therapeutics Secures $25 Million Series A Funding from Key Investors and Enters into Strategic Collaboration with Gilead Sciences Read more